Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04028843
Other study ID # PBRC 2018-039
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date July 12, 2019
Est. completion date August 31, 2025

Study information

Verified date May 2024
Source Pennington Biomedical Research Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study will test the effectiveness of a smartphone-based behavior modification program adapted for use in Women, Infants, and Children program in a state-wide, randomized controlled trial in 432 low-income women enrolled in the Louisiana Women, Infants, and Children program.


Description:

The study is a multi-site randomized controlled trial, testing the effectiveness of the smartphone-based behavior modification program in pregnant women within the Louisiana Women, Infants, and Children program. Equal number of participants will be randomized to either the intervention or the control. Although the intervention itself lasts 24 weeks (only during pregnancy), women will be enrolled in this study for approximately 18 months, from the 10-16th week of pregnancy until 12 month postpartum follow-up. Study outcomes will be assessed at three visits during pregnancy (early, mid, and late,) and three visits postpartum (1, 6, and 12 months).


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 351
Est. completion date August 31, 2025
Est. primary completion date August 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - Less than 16 weeks gestational age at screening visit - Have a BMI of 18.5 to 40 kg/m2 - Expecting a singleton pregnancy - Certified to receive Women, Infants, and Children services during current pregnancy - Has smartphone with internet access - Willing to be identifiable to other study participants in this study program Exclusion Criteria: - Smoking - Drug or alcohol use - Non-pregnancy related illness - Hypertension at screening visit - Current mental health issue or eating disorder - Inability to complete a behavioral run-in task - Plans to move out of the state in the next 18 months

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Healthy Beginnings
The program includes a 24 week intensive behavior modification program that targets healthy gestational weight gain through self-monitoring of weight and activity data, automated prescriptive feedback from the smartphone application, personalized feedback from counselors and, evidence-based behavioral intervention delivered throughout pregnancy.

Locations

Country Name City State
United States Pennington Biomedical Research Center Baton Rouge Louisiana

Sponsors (2)

Lead Sponsor Collaborator
Pennington Biomedical Research Center Louisiana Department of Health

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Women Who Have Excess Gestational Weight Gain Number of pregnant women who gain more weight during pregnancy than is recommended by the Institute of Medicine Gestational Weight Gain guidelines Approximately 6 months (from 10-16 weeks gestation to 35-38 weeks gestation)
Secondary Total Gestational Weight Gain Approximately 6 months (from 10-16 weeks gestation to 35-38 weeks gestation)
Secondary Gestational Weight Gain Per Week "per week" is included to adjust for the different length of time between weight measurements Approximately 6 months (from 10-16 weeks gestation to 35-38 weeks gestation)
See also
  Status Clinical Trial Phase
Completed NCT01858233 - The IBEP Study: an Intervention for Lifestyle Modification in Women With Gestational Diabetes N/A
Completed NCT01610752 - Personalized Management of Body Weight During Pregnancy N/A